Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Aug 2, 2022
Date Accepted: Apr 20, 2023

The final, peer-reviewed published version of this preprint can be found here:

Patients With Rare Diseases and the Power of Online Support Groups: Implications for the Medical Community

Ashtari S, Taylor A

Patients With Rare Diseases and the Power of Online Support Groups: Implications for the Medical Community

JMIR Form Res 2023;7:e41610

DOI: 10.2196/41610

PMID: 37707878

PMCID: 10540027

Rare Disease Patients and the Power of Online Support Groups: Implications for the Medical Community

  • Sadaf Ashtari; 
  • Adam Taylor

ABSTRACT

Background:

Previous studies have shown positive health impacts of using online support communities for informational support, daily living support and emotional support. The specifics of how these communities can be improved have not been studied in detail.

Objective:

This study will investigate various sources of information that patients with genetic disorders use to learn more about their condition. This study will also investigate benefits and disadvantages of the online platforms and how they can be improved.

Methods:

This study used quantitative and qualitative analyses. We undertook an online questionnaire survey and semi-structured qualitative interviews via Zoom. Questionnaire results were analyzed using descriptive analysis. Thematic coding with constant comparison was used for interview transcript analysis.

Results:

A total of 436 respondents completed some or all of the survey. The majority of participants are female (93.46%) and 24% of them are in the range of 25-34 years old. Around 81% of the participants have some type of college degree and 55% of them have graduate degrees. 49.39% of them are not currently employed. Most patients stated that their healthcare providers didn’t give accurate and complete information to patients regarding their health situation (mean 2.87, SD 1.34). Also, patients perceived their providers are not knowledgeable regarding online communities that discuss patients’ conditions (mean 1.93, SD 1.15). Patients are confident in using healthcare resources available in online health communities (mean 3.78, SD 1.13). We interviewed 30 participants. The demographic of interviewees was aligned with the survey participants. Nine different themes were identified based on the Qualtrics survey and qualitative interviews. Participants shared the pros and cons of different online support groups that they were using and gave suggestions for improvement. They requested a centralized database with different categories of resources classified based on different diseases. They also emphasized the importance of search features and the ability to find relevant information with a hashtag. Furthermore, they elaborated on privacy and security concerns they have regarding online support group platforms.

Conclusions:

Innovative rare disease patients are finding information not available from their healthcare providers on community support groups. The medical community and web developers have a great opportunity to help these people by engaging with their online communities.


 Citation

Please cite as:

Ashtari S, Taylor A

Patients With Rare Diseases and the Power of Online Support Groups: Implications for the Medical Community

JMIR Form Res 2023;7:e41610

DOI: 10.2196/41610

PMID: 37707878

PMCID: 10540027

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.